Articles By RheumNow
Slow Lung Decline Typical in Systemic Sclerosis
By RheumNow
The interstitial lung disease that develops in a subset of patients with systemic sclerosis tends to be heterogeneous, with the majority of patients experiencing a slow pattern of decline in lung function, analysis of outcomes in the European Scleroderma Trials and Research (EUSTAR) database foun
Read Article
Novel Biologic Promising in Mid-Stage Scleroderma Trial
By RheumNow
The anti-interleukin agent romilkimab showed significant benefits on skin fibrosis among patients with systemic sclerosis in a phase II trial, researchers reported.
Read Article
DMARDs for Early Rheumatoid Arthritis Have Cardiovascular Benefits
By RheumNow
Patients with RA have up to a three-fold increased risk of mortality versus the general population, largely due to an increased incidence of premature CVD, such as atherosclerosis and heart failure.
Read Article
Capsaicin Injection Improves Knee OA Pain
By RheumNow
Highly purified synthetic trans-capsaicin (CNTX‐4975) injected directly into the joint reduced pain in chronic knee osteoarthritis (OA), data from the open-label phase III VICTORY-3 trial showed.
Read Article
ICYMI: HCQ May Help Prevent Fetal Heart Block
By RheumNow
Hydroxychloroquine (HCQ) helped reduce recurrent maternal autoantibody-mediated congenital heart block (CHB) in fetuses, an open-label study suggested.
Read Article
Older Lupus Patients Can Stop HCQ Without Increasing Flare Risk
By RheumNow
Since patients with SLE have longer life expectancies in the modern era, they may be at elevated risk for HCQ adverse events, including maculopathy and cardiomyopathy. Therefore, Peter M. Izmirly, MD, of New York University School of Medicine in New York City, and colleagues assessed whether older SLE patients could safely discontinue HCQ.
Read Article
Treatments Differ Across Centers in Systemic JIA
By RheumNow
Significant variations were seen across hospitals in the treatment of children admitted with new-onset systemic juvenile idiopathic arthritis (JIA), despite increasing evidence of the efficacy of biologics and the hazards of extended glucocorticoid exposure, a retrospective cohort study found.
Read Article
In Lupus, Older Age and Male Sex Raise Cancer Risk
By RheumNow
Among patients with systemic lupus erythematosus (SLE), cancer risks overall were associated with older age at diagnosis and male sex, and lung cancer specifically was related to smoking, analysis of data from a large multicenter cohort found.
Read Article
ACP/AAFP Guidelines on Managing Musculoskeletal Pain
By RheumNow
Topical nonsteroidal anti-inflammatory drugs (NSAIDs) are recommended as first-line therapy in a new guideline for treating acute, non-low back pain from musculoskeletal injuries in outpatient settings.
Read Article
Cachexia Common in Lupus
By RheumNow
Cachexia is an underappreciated complication of systemic lupus erythematosus, researchers reported.
Read Article